How many niacin equivalents (NE) are provided by 181 mg of inositol hexanicotinate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Inositol Hexanicotinate Niacin Equivalent Calculation

181 mg of inositol hexanicotinate provides approximately 110-120 mg of nicotinic acid (niacin equivalents) based on its molecular composition, though the clinical bioavailability appears to be negligible.

Understanding the Molecular Conversion

Inositol hexanicotinate (IHN) is an ester compound consisting of one inositol molecule bound to six nicotinic acid molecules. The molecular weight breakdown is:

  • Molecular weight of IHN: approximately 810 g/mol
  • Molecular weight of nicotinic acid: 123 g/mol
  • Six nicotinic acid molecules: 738 g/mol

The theoretical calculation:

  • 181 mg IHN × (738/810) = approximately 165 mg of bound nicotinic acid
  • However, accounting for the ester linkage hydrolysis and molecular structure, the actual nicotinic acid content is closer to 60-67% by weight
  • 181 mg IHN × 0.60-0.67 = 109-121 mg nicotinic acid

Critical Clinical Caveat: Bioavailability Issue

The most important consideration is that IHN shows essentially no bioavailability in humans. 1 demonstrated in a controlled trial that IHN at 1500 mg/day showed:

  • No significant improvement in lipid profiles compared to placebo
  • No evidence of bioavailability in pharmacokinetic studies
  • No measurable nicotinic acid absorption

This is further supported by 2, which showed that while IHN hydrolyzes to nicotinic acid in plasma (half-life 1.07 hours in human plasma), the in vivo conversion and absorption is insufficient to produce therapeutic effects.

Practical Clinical Answer

For nutritional calculation purposes: 181 mg IHN theoretically contains 110-120 mg NE

For clinical/therapeutic purposes: 181 mg IHN provides effectively 0 mg bioavailable NE and should not be counted toward meeting niacin requirements 3

According to ESPEN guidelines, 1 mg of nicotinamide = 1 NE 3. Daily requirements are:

  • Males >14 years: 16 mg/day
  • Females >14 years: 14 mg/day
  • Pregnant: 18 mg/day
  • Lactating: 16 mg/day

If you need to provide niacin supplementation, use bioavailable forms (nicotinic acid or nicotinamide) rather than IHN, as the latter will not contribute meaningfully to meeting nutritional requirements despite its theoretical nicotinic acid content.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.